Deferred Tax Assets, Valuation Allowance of CytoDyn Inc. from 31 May 2012 to 31 May 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
CytoDyn Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 May 2012 to 31 May 2025.
  • CytoDyn Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 May 2025 was $126,203,000, a 1.9% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

CytoDyn Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $126,203,000 -$2,433,000 -1.9% 31 May 2025 10-K 25 Jul 2025 2025 FY
Q2 2024 $128,636,000 +$57,000 +0.04% 31 May 2024 10-K 25 Jul 2025 2025 FY
Q2 2023 $128,579,000 +$10,941,000 +9.3% 31 May 2023 10-K 25 Jul 2025 2025 FY
Q2 2022 $117,638,000 +$34,384,000 +41% 31 May 2022 10-K 15 Aug 2024 2024 FY
Q2 2021 $83,254,000 +$23,148,000 +39% 31 May 2021 10-K 15 Aug 2022 2022 FY
Q2 2020 $60,106,000 +$16,973,889 +39% 31 May 2020 10-K 30 Jul 2021 2021 FY
Q2 2019 $43,132,111 +$6,466,848 +18% 31 May 2019 10-K 14 Aug 2020 2020 FY
Q2 2018 $36,665,263 -$706,554 -1.9% 31 May 2018 10-K 14 Aug 2019 2019 FY
Q2 2017 $37,371,817 +$9,406,479 +34% 31 May 2017 10-K 27 Jul 2018 2018 FY
Q2 2016 $27,965,338 +$8,725,238 +45% 31 May 2016 10-K 20 Jul 2017 2017 FY
Q2 2015 $19,240,100 +$31,603,300 31 May 2015 10-K 19 Jul 2016 2016 FY
Q2 2014 $12,363,200 -$22,043,400 -228% 31 May 2014 10-K 10 Jul 2015 2015 FY
Q2 2013 $9,680,200 +$1,173,600 +14% 31 May 2013 10-K 10 Jul 2014 2014 FY
Q2 2012 $8,506,600 31 May 2012 10-K 29 Aug 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.